Benefit of Adding Trastuzumab to Second Line Chemotherapy in Breast Cancer Patients Previously Treated With Trastuzumab
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Vinorelbine|DRUG: Capecitabine|DRUG: Trastuzumab
Sponsor: Spanish Breast Cancer Research Group
Collaborators: Hoffmann-La Roche